Systems Pharmacology and Toxicology Training Program
Project Number5T32GM106999-10
Contact PI/Project LeaderPRATHER, PAUL L
Awardee OrganizationUNIV OF ARKANSAS FOR MED SCIS
Description
Abstract Text
Project Summary/Abstract:
Over the past few decades, our knowledge of the mechanisms by which cells interact with drugs and toxins has
exploded due to new molecular analysis techniques and the application of genomic methods. Accordingly, the
emphasis of graduate education in the disciplines of pharmacology and toxicology needs to shift from a
reductionist view to a systems approach in which doctoral students are comprehensively trained so they can
formulate a strategy to solve important biological questions not only at the molecular, cellular, and tissue levels
but also at the whole-animal level. Systems pharmacology and toxicology describes a field of study that considers
the broad view of drug action. A systems approach using in vivo animal models is necessary to establish efficacy,
safety and the pharmacodynamic/pharmacokinetic profile of candidate drugs but there is a shortage of students
trained in this area. This Systems Pharmacology and Toxicology (SPaT) Program is designed for PhD students
in their second year of graduate study pursuing dissertation research projects in the pharmacological sciences.
Trainees (2/year for up to 2 years of support) and training faculty (30 mentors and 4 teachers) are drawn from
the Graduate Program in Interdisciplinary Biomedical Sciences and the MD/PhD Program. The SPaT program
will train students to use an in vivo approach to answering relevant questions in pharmacology and toxicology
with emphasis on metabolism, drug design, pharmacodynamics, pharmacokinetics, and signaling. The rationale
for SPaT is that this type of training provides students with a much broader perspective on pharmacology and
toxicology that better prepares them to be leaders of multi-disciplinary research teams in the pharmacological
sciences. We will integrate SPaT into PhD training programs already active at our graduate training sites in the
Little Rock area that include faculty/scientists in the Colleges of Medicine, Pharmacy, and Public Health on the
UAMS, the Arkansas Children's Hospital campus, and at the Food and Drug Administration-funded National
Center for Toxicological Research. The unique focus of SPaT is training with in vivo systems pharmacological
and toxicological approaches and concepts. The objective of SPaT is to provide in vivo pharmacology and
toxicology training that complement the cellular and molecular training that students receive in their home
programs. The training program consists of didactic training in pharmacology, toxicology, physiology,
pharmacokinetics, metabolism, biostatistics, grant writing, and the Responsible Conduct of Research along with
laboratory research using an in vivo model of human disease. The SPaT program will also provide strong
mentoring, extensive networking, and teaching and leadership opportunities for its trainees through its
programmatic activities.
Public Health Relevance Statement
Project Narrative:
This Systems Pharmacology and Toxicology (SPaT) Program is designed for PhD students pursuing dissertation
research projects in the pharmacological sciences at the University of Arkansas for Medical Sciences. A systems
approach using in vivo animal models is necessary to establish efficacy, safety and the
pharmacodynamic/pharmacokinetic profile of candidate drugs but there is a shortage of students trained in this
area.
NIH Spending Category
Health DisparitiesMinority Health
Project Terms
Pharmacology and ToxicologySystemTraining Programs
No Sub Projects information available for 5T32GM106999-10
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5T32GM106999-10
Patents
No Patents information available for 5T32GM106999-10
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5T32GM106999-10
Clinical Studies
No Clinical Studies information available for 5T32GM106999-10
News and More
Related News Releases
No news release information available for 5T32GM106999-10
History
No Historical information available for 5T32GM106999-10
Similar Projects
No Similar Projects information available for 5T32GM106999-10